Amazon is on trial after U.S. Federal Trade Commission (FTC) attorneys accused the company of knowingly enrolling millions of customers into Prime without clear consent. The civil antitrust case, targeting Amazon and three executives, could lead to hundreds of millions in damages and fines of up to $53,000 per violation.
According to the FTC, Amazon designed its Prime sign-up and cancellation processes to maximize revenue at the expense of consumers. Attorney Jonathan Cohen told jurors that “more members, more money” was Amazon’s priority, even if customers did not want the subscription.
Prime costs $14.99 per month and offers benefits such as free shipping and streaming. However, the FTC claims Amazon lured shoppers with free trial offers without clearly disclosing that these automatically convert into paid memberships. Internal emails revealed that executives rejected design changes between 2017 and 2022 that would have clarified terms, fearing reduced sign-ups.
The FTC also highlighted Amazon’s so-called “Iliad flow,” a cancellation process requiring up to seven clicks, which misled customers into thinking they had already ended their subscription. Data showed tens of millions abandoned the process midway.
Amazon attorney Moez Kaba denied wrongdoing, arguing Prime’s terms were disclosed and cancellations were simple. He accused the FTC of misrepresenting evidence and insisted the law does not demand a “well-promoted or popular” cancellation method.
The trial, expected to last a month, will feature testimony from customers and Amazon employees. A judge has already ruled Amazon violated the Restore Online Shoppers’ Confidence Act (ROSCA) by collecting payment data before fully disclosing terms. This early ruling gives the FTC a strong position as it seeks to hold Amazon and its executives liable.


SK Hynix Soars 13% in Nasdaq Debut After Record $26.5 Billion IPO
Fast Retailing Raises Full-Year Forecast After Uniqlo Owner Beats Q3 Profit Estimates
Sara Duterte Impeachment Trial Opens, Putting 2028 Philippine Election in Focus
AstraZeneca Shares Sink After Wainua Trial Misses Key Heart Disease Goal
Paramount-Warner Bros. Discovery Merger Faces Lawsuit From 12 States
Trump Administration Sues Maryland Over Alleged Sanctuary Immigration Policies
DOJ Subpoenas New York Times Journalists Over Air Force One Leak Report
Supreme Court Backs Lisa Cook, Defends Federal Reserve Independence Against Trump Firing Attempt
Elon Musk Says Anthropic Leads AI Race as Claude Models Challenge OpenAI
Trump Administration Hands Over Key Evidence in Minnesota Immigration Shooting Investigations
Bayer Wins Major U.S. Supreme Court Roundup Lawsuit, Shares Surge
Kitron Q2 Revenue Beats Estimates as Defense Demand Lifts Growth
Australia Sues Amazon Over Prime Video Ads and Subscription Terms
ICC Says Darfur War Crimes Probe Reaches Breakthrough in Sudan Investigation 



